IR@PKUHSC  > 北京大学临床肿瘤学院  > 胃肠肿瘤中心
学科主题临床医学
Association between early tumour shrinkage and outcomes in RAS-wild type patients with metastatic colorectal cancer receiving first-line FOLFOX or FOLFIRI plus cetuximab once every 2 weeks in the APEC study
Cheng, A. L.1; Cornelio, G. H.2; Shen, L.3; Price, T. J.4; Yang, T. S.5; Chung, I. J.6; Dai, G.7; Lin, J. K.8; Sharma, A.9; Yeh, K. H.1; Ma, B.10; Zaatar, A.11; Guan, Z.12; Masood, N.13; Srimuninnimit, V.14; Yau, T. C.15; Beier, F.16; Chatterjee, S.17; Lim, R. S. C.18
刊名EUROPEAN JOURNAL OF CANCER
2015-09-01
suppl.3页:S367-S367
收录类别SCI ; ISTP
文章类型Meeting Abstract
WOS标题词Science & Technology
类目[WOS]Oncology
研究领域[WOS]Oncology
语种英语
WOS记录号WOS:000361887401459
引用统计
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/57716
专题北京大学临床肿瘤学院_胃肠肿瘤中心
作者单位1.San Juan de Dios Hosp, Dept Oncol, Pasay City, Philippines
2.Chang Gung Mem Hosp, Div Med Oncol, Taoyuan, Taiwan
3.Mt Miriam Canc Hosp, Dept Radiotherapy & Oncol, George Town, Malaysia
4.Aga Khan Univ & Hosp, Dept Med Oncol, Karachi, Pakistan
5.Siriraj Hosp, Div Oncol, Bangkok, Thailand
6.Merck KGaA, Global Biostat, Darmstadt, Germany
7.Merck Serono, Reg Med Affairs, Mumbai, Maharashtra, India
8.Natl Taiwan Univ Hosp, Dept Med Oncol, Taipei, Taiwan
9.Peking Univ, Canc Hosp & Inst, Dept Gastrointestinal Oncol, Beijing 100871, Peoples R China
10.Queen Elizabeth Hosp, Dept Haematol & Oncol, Woodville, SA 5011, Australia
11.Chonnam Natl Univ, Hwasun Hosp, Dept Hematol Oncol, Hwasun Eup, South Korea
12.Peoples Liberat Army, Gen Hosp, Dept Comprehens Treatment Oncol, Beijing, Peoples R China
13.Taipei Vet Gen Hosp, Div Colon & Rectal Surg, Taipei, Taiwan
14.All India Inst Med Sci, Dept Med Oncol, New Delhi, India
15.Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Sha Tin, Hong Kong, Peoples R China
16.Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China
17.Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
18.Natl Univ Singapore, Inst Canc, Dept Haematol Oncol, Singapore 117548, Singapore
推荐引用方式
GB/T 7714
Cheng, A. L.,Cornelio, G. H.,Shen, L.,et al. Association between early tumour shrinkage and outcomes in RAS-wild type patients with metastatic colorectal cancer receiving first-line FOLFOX or FOLFIRI plus cetuximab once every 2 weeks in the APEC study[J]. EUROPEAN JOURNAL OF CANCER,2015,suppl.3:S367-S367.
APA Cheng, A. L..,Cornelio, G. H..,Shen, L..,Price, T. J..,Yang, T. S..,...&Lim, R. S. C..(2015).Association between early tumour shrinkage and outcomes in RAS-wild type patients with metastatic colorectal cancer receiving first-line FOLFOX or FOLFIRI plus cetuximab once every 2 weeks in the APEC study.EUROPEAN JOURNAL OF CANCER,suppl.3,S367-S367.
MLA Cheng, A. L.,et al."Association between early tumour shrinkage and outcomes in RAS-wild type patients with metastatic colorectal cancer receiving first-line FOLFOX or FOLFIRI plus cetuximab once every 2 weeks in the APEC study".EUROPEAN JOURNAL OF CANCER suppl.3(2015):S367-S367.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Cheng, A. L.]的文章
[Cornelio, G. H.]的文章
[Shen, L.]的文章
百度学术
百度学术中相似的文章
[Cheng, A. L.]的文章
[Cornelio, G. H.]的文章
[Shen, L.]的文章
必应学术
必应学术中相似的文章
[Cheng, A. L.]的文章
[Cornelio, G. H.]的文章
[Shen, L.]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。